Bifogade filer
Last day of trading at Nasdaq First North
Kurs
+0,90%
Likviditet
0,04 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2025-02-17 | 09:00 | Bokslutskommuniké 2024 |
| 2024-11-19 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-07-31 | - | 15-6 2024 |
| 2024-05-23 | - | X-dag ordinarie utdelning NEOD 0.00 SEK |
| 2024-05-22 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2024-02-16 | - | Split NEOD 100:1 |
| 2024-02-02 | - | Extra Bolagsstämma 2024 |
| 2023-11-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-19 | - | Kvartalsrapport 2023-Q2 |
| 2023-07-27 | - | Extra Bolagsstämma 2023 |
| 2023-05-24 | - | X-dag ordinarie utdelning NEOD 0.00 SEK |
| 2023-05-23 | - | Årsstämma |
| 2023-05-11 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-17 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-20 | - | X-dag ordinarie utdelning NEOD 0.00 SEK |
| 2022-05-19 | - | Årsstämma |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-25 | - | Extra Bolagsstämma 2022 |
| 2022-02-16 | - | Bokslutskommuniké 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-27 | - | X-dag ordinarie utdelning NEOD 0.00 SEK |
| 2021-05-26 | - | Årsstämma |
| 2021-05-26 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-19 | - | Extra Bolagsstämma 2020 |
| 2020-11-19 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-29 | - | X-dag ordinarie utdelning NEOD 0.00 SEK |
| 2020-05-28 | - | Årsstämma |
| 2020-05-26 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-05 | - | Bokslutskommuniké 2019 |
| 2020-01-28 | - | Extra Bolagsstämma 2019 |
| 2019-11-21 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-24 | - | X-dag ordinarie utdelning NEOD 0.00 SEK |
| 2019-05-23 | - | Årsstämma |
| 2019-05-21 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-21 | - | Bokslutskommuniké 2018 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
NeoDynamics AB delists from the Nasdaq First North Growth Market. Today, July 30, 2024, is the final day of trading.
Information regarding the unofficial trading that will proceed through Pareto Securities post delisting was posted earlier this month. NeoDynamics will continue to communicate updates through the homepage.
For further information, please contact:
Matilda Salén, CEO NeoDynamics AB, phone +46 76-843 65 74 or e-mail matilda.salen@neodynamics.com
About NeoNavia
NeoNavia is a modern biopsy system with a completely new patented pulse technology intended for ultrasound-guided tissue sampling. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumor whilst enabling high-quality tissue samples from both breasts and lymph nodes. The pulse biopsy system NeoNavia is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment.
About NeoDynamics
NeoDynamics AB is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound-guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in Europe and launches in USA during 2024. NeoDynamic’s shares are listed on Nasdaq First North Growth Market Stockholm (ticker: NEOD). The company’s Certified Adviser is Redeye AB.
Attachments
Last day of trading at Nasdaq First North